RESISTANCE TO RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY - STUDIES IN EXPERIMENTAL MODELS OF ANEMIA AND CHRONIC KIDNEY DISEASE
Conversion from Epoetin Alfa to Darbepoetin Alfa: Effects on Patients' Hemoglobin and Costs to Canadian Dialysis Centres
Conversion from Epoetin Alfa to Darbepoetin Alfa: Effects on Patients' Hemoglobin and Costs to Canadian Dialysis Centres
Darbepoetin alfa: A new therapeutic agent for renal anemia - ScienceDirect
Erythropoietins: A common mechanism of action
Anemia management in Hemodialysis - ppt download
Conversion - Epoetin alfa (Procrit®) to Darbepoetin ... | GrepMed
Darbepoetin alfa: A new therapeutic agent for renal anemia - ScienceDirect
Erythropoietin: Uses, Interactions, Mechanism of Action | DrugBank Online
Erythropoiesis-stimulating agents (epoetin alfa, beta, theta and zeta; and, darbepoetin alfa) for treating cancer- treatment ind
Darbepoetin alfa: A new therapeutic agent for renal anemia - ScienceDirect
![PDF] Shifting Darbepoetin Alpha to Subcutaneous Methoxy Polyethylene Glycol- Epoetin Beta of Similar Doses and Extended Dose Intervals Effectively Maintains Hemoglobin Concentrations in Peritoneal Dialysis Patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f91306ab176272ee910094f0aa47de05a6c26329/3-Table1-1.png "PDF] Shifting Darbepoetin Alpha to Subcutaneous Methoxy Polyethylene Glycol- Epoetin Beta of Similar Doses and Extended Dose Intervals Effectively Maintains Hemoglobin Concentrations in Peritoneal Dialysis Patients | Semantic Scholar")
PDF] Shifting Darbepoetin Alpha to Subcutaneous Methoxy Polyethylene Glycol- Epoetin Beta of Similar Doses and Extended Dose Intervals Effectively Maintains Hemoglobin Concentrations in Peritoneal Dialysis Patients | Semantic Scholar
Erythropoietin, Darbepoetin alpha, Epoetin alpha, Pegylated erythropoietin, Haemoglobin.
Darbepoetin alfa - wikidoc
![PDF] Shifting Darbepoetin Alpha to Subcutaneous Methoxy Polyethylene Glycol- Epoetin Beta of Similar Doses and Extended Dose Intervals Effectively Maintains Hemoglobin Concentrations in Peritoneal Dialysis Patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f91306ab176272ee910094f0aa47de05a6c26329/3-Figure2-1.png "PDF] Shifting Darbepoetin Alpha to Subcutaneous Methoxy Polyethylene Glycol- Epoetin Beta of Similar Doses and Extended Dose Intervals Effectively Maintains Hemoglobin Concentrations in Peritoneal Dialysis Patients | Semantic Scholar")
PDF] Shifting Darbepoetin Alpha to Subcutaneous Methoxy Polyethylene Glycol- Epoetin Beta of Similar Doses and Extended Dose Intervals Effectively Maintains Hemoglobin Concentrations in Peritoneal Dialysis Patients | Semantic Scholar
Baseline Erythropoietin Alfa Dose vs Converted Darbepoetin Alfa Dose | Download Table
Darbepoetin Alfa | CancerQuest
Table 2 from Conversion from epoetin alfa to darbepoetin alfa: effects on patients' hemoglobin and costs to canadian dialysis centres. | Semantic Scholar
Switch From Epoetin Beta to Darbepoetin Alfa Treatment of Anemia in Taiwanese Hemodialysis Patients: Dose Equivalence by Hemoglobin Stratification - Liao - 2016 - Therapeutic Apheresis and Dialysis - Wiley Online Library
Epoetin alfa and Darbepoetin alfa Has Maximum Share of 80%
Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study | SpringerLink
Darbepoetin Alfa Dosage Changes | Download Table
